Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05553288 · ClinicalTrials.gov registry record
Effectiveness of a Real Time Data Safety Study Tool
A clinical trial of Study Subjects Currently Enrolled in a Clinical Research Trial, sponsored by Perseverance Research Center.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05553288: Completed study of Study Subjects Currently Enrolled in a Clinical Research Trial, sponsored by Perseverance Research Center.
NCT05553288 is a study of Study Subjects Currently Enrolled in a Clinical Research Trial that has completed, run by Perseverance Research Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05553288, a study of Study Subjects Currently Enrolled in a Clinical Research Trial, has completed, sponsored by Perseverance Research Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Study RTD-01 is a non-interventional, pilot study designed to determine if a specific coded SMS text message study tool is effective in collecting daily real time safety data in subjects participating in clinical trials.
Primary Outcome
Data collected daily through secure text messaging
Conditions Studied
Study Locations (1)
Arizona
- Perseverance Research Center, LLC - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2022-11-05 |
What the finished NCT05553288 record still lists
NCT05553288 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Study Subjects Currently Enrolled in a Clinical Research Trial appearing as the primary indexed condition, and to 0 interventions.
NCT05553288 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05553288 about?
NCT05553288 is a clinical study titled "Effectiveness of a Real Time Data Safety Study Tool". Study RTD-01 is a non-interventional, pilot study designed to determine if a specific coded SMS text message study tool is effective in collecting daily real time safety data in subjects participating in clinical trials.
What is the current status of trial NCT05553288?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-08-01. Estimated completion is 2022-11-05.
What conditions does trial NCT05553288 study?
This clinical trial studies the following conditions: Study Subjects Currently Enrolled in a Clinical Research Trial.
Who is sponsoring clinical trial NCT05553288?
This trial is sponsored by Perseverance Research Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05553288 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI